# Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke.

> **NCT01388738** · PHASE3 · COMPLETED · sponsor: **Clinical Institute of the Brain, Russia** · enrollment: 30 (estimated)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** citicoline
- **DRUG:** L-Alpha glycerylphosphorylcholine
- **DRUG:** cerebrolysin

## Key facts

- **NCT ID:** NCT01388738
- **Lead sponsor:** Clinical Institute of the Brain, Russia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-10
- **Final completion:** 2011-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-12-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01388738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01388738, "Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke.". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT01388738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
